AI-generated summary
The authors ran a randomized, double-blind crossover trial in 12 male COPD patients comparing one photobiomodulation session on the respiratory muscles with a sham session. They report no significant changes in lung function, thoracoabdominal mobility or respiratory muscle strength, but a significant increase in distance walked on the 6-minute walk test after the active session compared with baseline.
- Participants
- 12
- Who or what was studied
- Twelve male patients with chronic obstructive pulmonary disease (COPD)
- Wavelengths
- 630, 830 nm
- Limits stated in the abstract
- The sample was small (12 men) and the abstract reports only acute effects measured over 24 hours.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 10 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Placebo-controlled, Near-infrared, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.